faCellitate GmbH, a leading innovator in defined surface coatings for life science consumables, is proud to announce the appointment of Heinz Schmid to its Advisory Board. A globally recognized expert in the life sciences industry, Schmid brings over three decades of leadership experience, including 19 years as Managing Director of Greiner Bio-One Germany and 13 years as CEO of the Bioscience Business Unit at Greiner Bio-One International GmbH.
With his deep industry knowledge and strategic insight, Schmid will play a pivotal role in guiding faCellitate’s growth and innovation roadmap, particularly in advancing technologies that support the future of stem cell therapies and 3D cell culture.
“It is a special honour to welcome Heinz Schmid to the faCellitate Advisory Board,” said Dr. Simon Widmaier, CEO of faCellitate. “His unparalleled expertise will be instrumental as we continue to redefine the standards for functional life science consumables. This appointment marks a significant milestone in our mission to empower researchers worldwide.”
“I am excited to join faCellitate’s Advisory Board and contribute to their mission of advancing life science research,” said Heinz Schmid. “faCellitate’s innovative approach and commitment to excellence align perfectly with my values. I look forward to supporting the team in driving impactful scientific progress.”
With his deep industry knowledge and strategic insight, Schmid will play a pivotal role in guiding faCellitate’s growth and innovation roadmap, particularly in advancing technologies that support the future of stem cell therapies and 3D cell culture.
“It is a special honour to welcome Heinz Schmid to the faCellitate Advisory Board,” said Dr. Simon Widmaier, CEO of faCellitate. “His unparalleled expertise will be instrumental as we continue to redefine the standards for functional life science consumables. This appointment marks a significant milestone in our mission to empower researchers worldwide.”
“I am excited to join faCellitate’s Advisory Board and contribute to their mission of advancing life science research,” said Heinz Schmid. “faCellitate’s innovative approach and commitment to excellence align perfectly with my values. I look forward to supporting the team in driving impactful scientific progress.”
